scarring
22.05.2023
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
12.10.2017
New patient group „men“ – hyaluronic acid as an important tool
In our dermatology practice we use increasingly cross-linked fillers in men, such as Z FILL Deep2 for regenerative augmentation. On behalf of a 47 year old man, the approach and […]
13.07.2016
Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary
Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock […]